09:55 AM EST - Cipher Pharmaceuticals Inc. : announced it has entered into a definitive distribution and supply agreement with Laboratorios Andrómaco S.A. under which Cipher has granted Andrómaco the exclusive right to market, sell and distribute Cipher's isotretinoin capsules in Chile. Cipher Pharmaceuticals Inc.
shares T.DND are trading up $0.13 at $8.85.
